Medical research

Study unveils picolinic acid's broad-spectrum antiviral abilities

Picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses, according to a new study by researchers at the Indian Institute of Science ...

Diseases, Conditions, Syndromes

COVID-19 may have spread between humans, deer

New research shows that humans and deer passed the coronavirus back and forth in late 2021 and early 2022, raising concerns that this animal reservoir could become a source of new variants.

Immunology

COVID-19 vaccines produce antibody response in the nasal mucosa

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that too. The nasal cavity is well-equipped with sticky mucus that traps pathogens and serves as an important ...

Diseases, Conditions, Syndromes

Rapid inactivation of human respiratory RNA viruses by DUV LEDs

Human respiratory RNA viruses, such as SARS-CoV-2 and influenza A virus (IAV), spread rapidly in the human population by airway transmission and caused substantial morbidity, mortality, economic losses, and pandemic diseases ...

Diseases, Conditions, Syndromes

Study: At-home rapid COVID tests may miss many infections

For the last couple of years, the rapid at-home COVID tests that can identify an infection with a simple swab of the nose have been a mainstay of efforts to diagnose infection with the SARS-CoV-2 virus and prevent its spread.

Diseases, Conditions, Syndromes

Nasal vaccine against coronavirus further improved

After having successfully tested a mucosal vaccine against coronavirus in animals just months ago, Berlin scientists have now further developed their live SARS-CoV-2 vaccine. Researchers at Freie Universität Berlin have ...

page 7 from 40